Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gecacitinib-Corticosteroids for Grade II-IV aGVHD
NCT07185633Phase 2Recruiting
- Start
- Jan 2026
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of jaktinib in Acute Graft-Versus-Host Disease (aGvHD). Started Jan 2026; status: recruiting.
02
Drugs
jaktinib
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT07185633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07185633.